MedTrace Logo

Pharmacokinetic Study Comparing Salmeterol/Fluticasone Easyhaler Products and Seretide Diskus

NCT02162485 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 129

Last updated 2015-09-29

No results posted yet for this study

Summary

The purposes of this study is to compare the test products Salmeterol/fluticasone Easyhaler with marketed product Seretide Diskus in terms of the drug absorbed into the blood stream

Conditions

Interventions

DRUG

Salmeterol/fluticasone Easyhaler

DRUG

Salmeterol/fluticasone Easyhaler with charcoal

DRUG

Seretide Diskus

DRUG

Seretide Diskus with charcoal

Sponsors & Collaborators

  • Orion Corporation, Orion Pharma

    lead INDUSTRY

Principal Investigators

  • Merja Mäkitalo · Orion Corporation, Orion Pharma

  • Leena Mattila, MD, PhD · Orion Pharma Clinical Pharmacology Unit, Espoo, Finland

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2015-09-30
Completion
2015-09-30

Countries

  • Finland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02162485 on ClinicalTrials.gov